Status:
UNKNOWN
An Examination of the Use of Electrophysiological Brain Monitoring to Direct the Treatment of Mild Cognitive Impairment
Lead Sponsor:
Brainmarc Ltd.
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
65-120 years
Phase:
NA
Brief Summary
The problem of cognitive decline among the aging population has become a significant health burden, especially in light of the increase in the prevalence of dementia with age For patients with MCI (Mi...
Eligibility Criteria
Inclusion
- Male or female above the age of 65 years
- Ability to read, write and understand the Hebrew language so to comply with study demands.
- Diagnosed with Amnestic MCI. Mini Mental State Examination (MMSE), A score of MSSE ≥27 for college educated subjects and MSSE ≥ 26 for all others; and (CDR) Clinical Dementia Rating, 0.5 ≥ CDR
- Diagnosed with memory impairment, Visual Paired Association = VPA (WMS-R), for subjects of ages 65-70, 16.5 ≥ WMS-R and for subjects of age above 71, 15.5 ≥ WMS-R
Exclusion
- Diagnosed with major psychiatric or neurological disorder.
- A user of recreational or illicit drugs or has had a recent history of drug or alcohol abuse or dependence.
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03375151
Start Date
February 1 2018
End Date
April 1 2019
Last Update
December 15 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.